ImmuPharma plc (LON:IMM – Get Free Report)’s share price was down 14.6% during mid-day trading on Tuesday . The company traded as low as GBX 3.20 ($0.04) and last traded at GBX 3.20 ($0.04). Approximately 13,200,714 shares were traded during mid-day trading, a decline of 53% from the average daily volume of 28,314,303 shares. The stock had previously closed at GBX 3.75 ($0.05).
ImmuPharma Trading Down 9.5 %
The business’s 50-day moving average price is GBX 1.54 and its 200-day moving average price is GBX 1.68. The stock has a market cap of £10.93 million, a PE ratio of -262.50 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Read More
- Five stocks we like better than ImmuPharma
- 10 Best Airline Stocks to Buy
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Where to Find Earnings Call Transcripts
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
